0001| HOUSE BILL 84 | 0002| 43rd legislature - STATE OF NEW MEXICO - first session, 1997 | 0003| INTRODUCED BY | 0004| GARY K. KING | 0005| | 0006| | 0007| | 0008| | 0009| | 0010| AN ACT | 0011| RELATING TO LICENSURE; AMENDING AND ENACTING SECTIONS OF THE | 0012| PHARMACY ACT. | 0013| | 0014| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: | 0015| Section 1. Section 61-11-1 NMSA 1978 (being Laws 1969, | 0016| Chapter 29, Section 1) is amended to read: | 0017| "61-11-1. SHORT TITLE.--[This act] Chapter 61, Article | 0018| 11 NMSA 1978 may be cited as the "Pharmacy Act"." | 0019| Section 2. A new section of the Pharmacy Act is enacted | 0020| to read: | 0021| "[NEW MATERIAL] LEGISLATIVE FINDINGS--PURPOSE OF ACT.-- | 0022| A. The legislature finds that the practice of | 0023| pharmacy in New Mexico is a professional practice affecting the | 0024| public health, safety and welfare and is subject to regulation | 0025| and control in the public interest. The legislature finds | 0001| further that it is a matter of public interest and concern that | 0002| the practice of pharmacy as defined in the Pharmacy Act merit | 0003| and receive the confidence of the public, and that only | 0004| qualified persons be permitted to engage in the practice of | 0005| pharmacy so that the quality of drugs and related devices | 0006| distributed in New Mexico is ensured. | 0007| B. The purpose of the Pharmacy Act is to promote, | 0008| preserve and protect the public health, safety and welfare by | 0009| and through the effective control and regulation of the | 0010| practice of pharmacy, including the licensure of pharmacists | 0011| and pharmacist interns and registration of pharmacy | 0012| technicians; the licensure, control and regulation of all sites | 0013| or persons, in or out of state, who distribute, manufacture or | 0014| sell drugs or devices used in the dispensing and administration | 0015| of drugs in New Mexico; and the regulation and control of such | 0016| other materials as may be used in the diagnosis, treatment and | 0017| prevention of injury, illness or disease of a patient or other | 0018| person." | 0019| Section 3. Section 61-11-2 NMSA 1978 (being Laws 1969, | 0020| Chapter 29, Section 2, as amended) is amended to read: | 0021| "61-11-2. DEFINITIONS.--As used in the Pharmacy Act: | 0022| A. "administer" means [giving a unit dose of | 0023| medication to a patient as a result of an order of a licensed | 0024| practitioner] the direct application of a drug to the body of | 0025| a patient or research subject by injection, inhalation, | 0001| ingestion or any other means; | 0002| B. "board" means the board of pharmacy; | 0003| C. ["compound"] "compounding" means [taking | 0004| two or more measured ingredients and fabricating them into a | 0005| single preparation, usually referred to as a dosage form, | 0006| except for preparations that involve repetitive tasks that do | 0007| not require the professional judgment of a licensed pharmacist; | 0008| provided that such preparations will be defined in regulations | 0009| adopted by the board] preparing, mixing, assembling, | 0010| packaging or labeling a drug or device as the result of a | 0011| licensed practitioner's prescription or initiative based on the | 0012| practitioner-patient-pharmacist relationship in the course of | 0013| professional practice or for the purpose of, or as an incident | 0014| to, research, teaching or chemical analysis and not for sale or | 0015| dispensing. "Compounding" also includes preparing drugs or | 0016| devices in anticipation of a prescription based on routine, | 0017| regularly observed prescribing patterns; | 0018| D. "confidential information" means information in | 0019| the patient's records accessed, maintained by or transmitted to | 0020| the pharmacist or communicated to the patient as part of | 0021| patient counseling that is privileged and may be released only | 0022| to the patient or, as the patient directs, to those licensed | 0023| practitioners and other authorized health care professionals | 0024| when, in the pharmacist's professional judgment, such release | 0025| is necessary to protect the patient's health and well being; | 0001| and to such other persons authorized by law to receive such | 0002| information, regardless of whether such information is on | 0003| paper, preserved on microfilm or stored on electronic media; | 0004| [D.] E. "consulting pharmacist" means a | 0005| pharmacist whose services are engaged on a routine [part- | 0006| time] basis by a hospital or other health care facility | 0007| [(1) to assist in drawing up correct | 0008| procedures, rules and regulations for the distribution of | 0009| drugs; | 0010| (2) to assume the overall responsibility for | 0011| the system of control and distribution of drugs; | 0012| (3) to see that a designated person has the | 0013| responsibility of day-to-day operation of the hospital pharmacy | 0014| or drug room; and | 0015| (4) to visit the hospital pharmacy or drug | 0016| room on a regularly scheduled basis in the course of his | 0017| duties] and who is responsible for the distribution, receipt | 0018| and storage of drugs according to the state and federal | 0019| regulations; | 0020| F. "custodial care facility" means a nursing home, | 0021| retirement care, mental care or other facility that provides | 0022| extended health care; | 0023| [E.] G. "dangerous drug" means a drug that is | 0024| [determined by law to be unsafe for self-medication and that | 0025| is enumerated in the New Mexico Drug, Device and Cosmetic Act] | 0001| required by an applicable federal or state law or rule to be | 0002| dispensed pursuant to a prescription or is restricted to use by | 0003| licensed practitioners; or that is required by federal law to | 0004| be labeled with either of the following statements prior to | 0005| being dispensed or delivered: | 0006| (1) "caution: federal law prohibits | 0007| dispensing without a prescription"; or | 0008| (2) "caution: federal law restricts this drug | 0009| to use by or on the order of a licensed veterinarian"; | 0010| H. "device" means an instrument, apparatus, | 0011| implement, machine, contrivance, implant or similar or related | 0012| article, including a component part or accessory, that is | 0013| required by federal law to bear the label, "caution: federal | 0014| or state law requires dispensing by or on the order of a | 0015| physician"; | 0016| [F.] I. "dispense" means [issuing to a patient | 0017| or a person acting on his behalf one or more unit doses of | 0018| medication and may result from compounding or from repackaging | 0019| from a bulk or original container] the interpretation, | 0020| evaluation and implementation of a prescription, including the | 0021| preparation and delivery of a drug or device to a patient or | 0022| patient's agent in a suitable container appropriately labeled | 0023| for subsequent administration to or use by a patient; | 0024| J. "distribute" means the delivery of a drug or | 0025| device other than by administering or dispensing; | 0001| [G.] K. "drug" means: | 0002| (1) [articles] an article recognized [in | 0003| the United States pharmacopoeia, homeopathic pharmacopoeia or | 0004| national formulary or any supplement to any of them] as a | 0005| drug in any official compendium or its supplement that is | 0006| designated from time to time by the board for use in the | 0007| diagnosis, cure, mitigation, treatment or prevention of disease | 0008| in humans or other animals; | 0009| (2) [articles] an article intended for use | 0010| in the diagnosis, cure, mitigation, treatment or prevention of | 0011| diseases in [man or animal] humans or other animals; | 0012| (3) [articles] an article, other than | 0013| food, that [affect] affects the structure or any function | 0014| of the body of [man or animal] humans or other animals; and | 0015| (4) [articles] an article intended for use | 0016| as a component of an article described in Paragraph (1), (2) | 0017| or (3) of this subsection; [but does not include instruments, | 0018| apparatus or contrivances, including their components, parts or | 0019| accessories, known as devices, intended for use in the | 0020| diagnosis, cure, mitigation, treatment or prevention of | 0021| diseases in man or animal or that affect the structure or any | 0022| function of the body of man or animal; | 0023| H. "drug room" means that area provided only for | 0024| the proper and safe storage, preservation and control of | 0025| drugs;] | 0001| L. "drug regimen review" includes an evaluation of | 0002| a prescription and patient record for: | 0003| (1) known allergies; | 0004| (2) rational therapy contraindications; | 0005| (3) reasonable dose and route of | 0006| administration; | 0007| (4) reasonable directions for use; | 0008| (5) duplication of therapy; | 0009| (6) drug-drug interactions; | 0010| (7) adverse drug reactions; and | 0011| (8) proper use and optimum therapeutic | 0012| outcomes; | 0013| M. "electronic transmission" means transmission of | 0014| information in electronic form or the transmission of the exact | 0015| visual image of a document by way of electronic equipment; | 0016| [I.] N. "hospital" means an institution [for | 0017| the reception and care of the ill or infirm] that is licensed | 0018| as a hospital by the department of health; | 0019| [J. "hospital pharmacy" means a pharmacy | 0020| maintained in a hospital;] | 0021| O. "labeling" means the process of preparing and | 0022| affixing a label to any drug container exclusive of the | 0023| labeling by a manufacturer, packer or distributor of a | 0024| nonprescription drug or commercially packaged prescription drug | 0025| or device; and which label includes all information required by | 0001| federal or state law or regulations adopted pursuant to federal | 0002| or state law; | 0003| [K.] P. "licensed practitioner" means a person | 0004| engaged in a profession licensed by any state, territory or | 0005| possession of the United States who, within the limits of his | 0006| license, may lawfully prescribe, dispense or administer drugs | 0007| for the treatment of a patient's condition; | 0008| Q. "manufacturing" means the production, | 0009| preparation, propagation, conversion or processing of a drug or | 0010| device, either directly or indirectly, by extraction from | 0011| substances of natural origin or independently by means of | 0012| chemical or biological synthesis and includes packaging or | 0013| repackaging, labeling or relabeling and the promotion and | 0014| marketing of such drugs or devices. "Manufacturing" also | 0015| includes the preparation and promotion of commercially | 0016| available products from bulk compounds for resale by | 0017| pharmacies, licensed practitioners or other persons; | 0018| [L.] R. "nonprescription drugs" means non- | 0019| narcotic medicines or drugs that may be sold without a | 0020| prescription and are prepackaged for use by a consumer and are | 0021| labeled in accordance with the laws and regulations of the | 0022| state and federal governments; | 0023| [M.] S. "nonresident pharmacy" means any | 0024| pharmacy located outside New Mexico that ships, mails or | 0025| delivers, in any manner, drugs into New Mexico; | 0001| [N.] T. "patient counseling" means the oral | 0002| communication [with] by the pharmacist of information to a | 0003| patient or his agent or caregiver regarding [dispensing of a | 0004| prescription] proper use of a drug or [drugs] device; | 0005| [O.] U. "person" means an individual, | 0006| corporation, partnership, [or] association [and, when the | 0007| context requires, includes a hospital, nursing home or clinic] | 0008| or other legal entity; | 0009| V. "pharmaceutical care" means the provision of | 0010| drug therapy and other patient care services intended to | 0011| achieve definite outcomes that improve a patient's quality of | 0012| life, including identifying potential and actual drug-related | 0013| problems, resolving actual drug-related problems and preventing | 0014| potential drug-related problems; | 0015| [P.] W. "pharmacist" means a person who [holds | 0016| a current license] is licensed as a pharmacist in this | 0017| state; | 0018| X. "pharmacist in charge" means a pharmacist who | 0019| accepts responsibility for the operation of a pharmacy in | 0020| conformance with all laws and rules pertinent to the practice | 0021| of pharmacy and the distribution of drugs and who is personally | 0022| in full and actual charge of the pharmacy and its personnel; | 0023| [Q.] Y. "pharmacy" means [any store, | 0024| laboratory or] a licensed place of business where drugs are | 0025| [sold at retail or where physicians' prescriptions are | 0001| compounded or] compounded or dispensed [or both, but does | 0002| not include the place used by a drug manufacturer or wholesale | 0003| drug distributor or the place of business of a nonregistered | 0004| person selling non-narcotic proprietary preparations or | 0005| remedies] and pharmaceutical care is provided; | 0006| [R.] Z. "pharmacist intern" means a person | 0007| [registered] licensed by the board to train under a | 0008| pharmacist [in accordance with regulations of the board and | 0009| who is entitled to compound and dispense drugs and poisons | 0010| under the personal supervision of a pharmacist]; | 0011| AA. "pharmacy technician" means a person who is | 0012| registered to perform repetitive tasks not requiring the | 0013| professional judgment of a pharmacist; | 0014| [S.] BB. "practice of pharmacy" means | 0015| [engaging in the preparation, compounding and dispensing of | 0016| drugs and includes the identification, preservation, proper and | 0017| safe storage, selection, combination, analysis, | 0018| standardization, labeling, manufacturing, re-packaging and | 0019| distribution of drugs, the reconstitution or preparation of | 0020| intravenous admixtures, the proper maintenance of any records | 0021| required by state or federal law and counseling with respect to | 0022| pharmaceutical practices] the interpretation, evaluation and | 0023| implementation of a lawful order of a licensed practitioner; | 0024| the dispensing of prescriptions; the participation in drug and | 0025| device selection, drug administration, drug regimen reviews and | 0001| drug or drug-related research; the provision of patient | 0002| counseling and pharmaceutical care; the responsibility for | 0003| compounding and labeling of drugs and devices; the proper and | 0004| safe storage of drugs and devices; and the maintenance of | 0005| proper records; | 0006| [T.] CC. "prescription" means an order given | 0007| individually for the person for whom prescribed, either | 0008| directly from a licensed practitioner or his agent to the | 0009| pharmacist, including electronic transmission or indirectly | 0010| by means of a written order signed by the prescriber, that | 0011| bears the name and address of the prescriber, his license | 0012| classification, the name and address of the patient, the name | 0013| and quantity of the drug prescribed, directions for use and the | 0014| date of issue; | 0015| [U. "supportive personnel" means persons who are | 0016| not pharmacists or pharmacist interns, who, under the | 0017| supervision of a licensed pharmacist, perform repetitive tasks | 0018| not requiring the professional judgment of a pharmacist in | 0019| accordance with rules and regulations adopted by the board; | 0020| and] | 0021| DD. "significant adverse drug reaction" means a | 0022| drug-related incident that may result in harm, injury or death | 0023| to the patient; and | 0024| [V.] EE. "wholesale drug distributor" means a | 0025| person engaged in the wholesale distribution of prescription | 0001| drugs, including manufacturers, repackers, own-label | 0002| distributors, private-label distributors, jobbers, brokers, | 0003| manufacturer's warehouses, distributor's warehouses, chain drug | 0004| warehouses, wholesale drug warehouses, independent wholesale | 0005| drug traders and retail pharmacies that conduct wholesale | 0006| distribution." | 0007| Section 4. Section 61-11-4 NMSA 1978 (being Laws 1969, | 0008| Chapter 29, Section 3, as amended) is amended to read: | 0009| "61-11-4. BOARD CREATED--MEMBERS--QUALIFICATIONS--TERMS-- | 0010| VACANCIES--REMOVAL.-- | 0011| A. There is created the "board of pharmacy". The | 0012| board consists of nine members, each of whom shall be a citizen | 0013| of the United States and a resident of New Mexico. | 0014| B. Five members shall be pharmacists appointed by | 0015| the governor for staggered terms of five years each from lists | 0016| submitted to the governor by the New Mexico pharmaceutical | 0017| association, which lists contain the names of two pharmacists | 0018| residing in each of the five pharmacy districts. One of the | 0019| pharmacist members shall be appointed for a term ending July 1, | 0020| 1970 and one pharmacist member shall be appointed for a term | 0021| ending on July 1 of each of the following four years. | 0022| Thereafter, appointments of pharmacist members shall be made | 0023| for five years or less each and made in such a manner that the | 0024| term of one pharmacist member expires on July 1 of each year. | 0025| [Not more than] One pharmacist member shall [come from a] | 0001| be appointed from each pharmacy district. Each pharmacist | 0002| member of the board shall have been actively engaged in the | 0003| pharmaceutical profession in this state for at least three | 0004| years immediately prior to his appointment and shall have had a | 0005| minimum of eight years of practical experience as a pharmacist. | 0006| A vacancy shall be filled by appointment by the governor for | 0007| the unexpired term from lists submitted by the New Mexico | 0008| pharmaceutical association to the governor. Pharmacist members | 0009| shall reside in the district from which they are appointed. | 0010| C. Three members of the board shall be appointed | 0011| by the governor to represent the public. The public members | 0012| of the board shall not have been licensed as pharmacists or | 0013| have any significant financial interest, whether direct or | 0014| indirect, in the [occupation] profession regulated. A | 0015| vacancy in [the] a public [members' terms] member's | 0016| term shall be filled by appointment by the governor for the | 0017| unexpired term. Initial appointments of public members shall | 0018| be made for staggered terms of five years or less each and made | 0019| in such a manner that not more than two [board] public | 0020| members' terms shall expire on July 1 of each year. | 0021| D. One member of the board shall be a [hospital] | 0022| pharmacist [selected] appointed at large from a list | 0023| submitted to the governor by the New Mexico society of | 0024| [hospital] health systems pharmacists. [On July 1, 1985, | 0025| the governor shall appoint a hospital pharmacist member to the | 0001| board for a term expiring July 1, 1990 and successors to the | 0002| hospital pharmacist] The member shall be appointed by the | 0003| governor to [terms] a term of five years. A vacancy in | 0004| the [hospital pharmacist member] member's term shall be | 0005| filled by appointment by the governor for the unexpired term | 0006| from a list submitted to the governor by the New Mexico society | 0007| of [hospital] health systems pharmacists. | 0008| E. There are created five pharmacy districts as | 0009| follows: | 0010| (1) northeast district, which shall be | 0011| composed of the counties of Colfax, Guadalupe, Harding, Los | 0012| Alamos, Mora, Quay, Rio Arriba, Sandoval, San Miguel, Santa Fe, | 0013| Taos, Torrance and Union; | 0014| (2) northwest district, which shall be | 0015| composed of the counties of McKinley, San Juan, Valencia and | 0016| Cibola; | 0017| (3) central district, which shall be composed | 0018| of the county of Bernalillo; | 0019| (4) southeast district, which shall be | 0020| composed of the counties of Chaves, Curry, DeBaca, Eddy, Lea | 0021| and Roosevelt; and | 0022| (5) southwest district, which shall be | 0023| composed of the counties of Catron, Dona Ana, Grant, Hidalgo, | 0024| Lincoln, Luna, Otero, Sierra and Socorro. | 0025| F. No board member shall serve more than two full | 0001| terms, consecutive or otherwise. | 0002| G. Any board member failing to attend three | 0003| consecutive regular meetings is automatically removed as a | 0004| member of the board. | 0005| H. The governor may remove any member of the board | 0006| for neglect of any duty required by law, for incompetency or | 0007| for unprofessional conduct and shall remove any board member | 0008| who violates any provision of the Pharmacy Act. | 0009| [I. If a vacancy occurs on the board for any | 0010| reason, the secretary of the board shall immediately notify the | 0011| governor, the board members and any generally recognized | 0012| association or organization of pharmacists of the reason for | 0013| its occurrence and the action taken by the board, so as to | 0014| expedite the appointment of a new board member.]" | 0015| Section 5. Section 61-11-5 NMSA 1978 (being Laws 1969, | 0016| Chapter 29, Section 4) is amended to read: | 0017| "61-11-5. BOARD MEETINGS--QUORUM--OFFICERS--BONDS-- | 0018| EXPENSES.-- | 0019| A. The board shall annually elect a chairman, vice | 0020| chairman and secretary-treasurer from its membership. | 0021| B. The board shall meet at least once every three | 0022| months. Special meetings may be called by the chairman and | 0023| shall be called upon the written request of two or more members | 0024| of the board. Notification of special meetings shall be made | 0025| by certified mail unless the notice is waived by the entire | 0001| board and noted in the minutes. Notice of all regular meetings | 0002| shall be made by regular mail at least ten days prior to the | 0003| meeting, and copies of the minutes of all meetings shall be | 0004| mailed to each board member within forty-five days after any | 0005| meeting. | 0006| C. A majority of the board constitutes a quorum. | 0007| [D. The executive officer and any member or | 0008| employee of the board who handles money or who certifies the | 0009| receipt or disbursement of money received by the board shall, | 0010| within thirty days after appointment, execute a bond in a sum | 0011| set by the board, conditioned on the faithful performance of | 0012| the duties of the office and an accounting for all funds coming | 0013| into his hands. The bonds shall be signed by a surety company | 0014| authorized to do business in this state and be filed with and | 0015| approved by the board. | 0016| E.] D. Members of the board shall be reimbursed | 0017| as provided in the Per Diem and Mileage Act and shall receive | 0018| no other compensation, perquisite or allowance." | 0019| Section 6. Section 61-11-6 NMSA 1978 (being Laws 1969, | 0020| Chapter 29, Section 5, as amended) is amended to read: | 0021| "61-11-6. POWERS AND DUTIES OF BOARD.-- | 0022| A. The board shall: | 0023| [A.] (1) adopt, [regularly review and | 0024| revise] amend or repeal rules and regulations necessary to | 0025| carry out the provisions of the Pharmacy Act [after hearings | 0001| open to the public] in accordance with the provisions of the | 0002| Uniform Licensing Act; | 0003| [B.] (2) provide for [at least two] | 0004| examinations [a year] of applicants for [registration] | 0005| licensure as pharmacists; | 0006| [C.] (3) provide for the [registration | 0007| and the annual] issuance and renewal of licenses for | 0008| pharmacists; | 0009| [D.] (4) require and establish criteria | 0010| for continuing education as a condition of annual renewal of | 0011| [annual] licensure for pharmacists; | 0012| [E.] (5) provide for the [registration | 0013| of] issuance and annual renewal of licenses for pharmacist | 0014| interns [their certification, annual renewal of | 0015| certification] and for their training, supervision and | 0016| discipline; | 0017| [F.] (6) provide for the licensing of | 0018| retail pharmacies, nonresident pharmacies, wholesale drug | 0019| distributors, drug manufacturers, hospital pharmacies [and the | 0020| drug rooms of hospitals], nursing home drug facilities, | 0021| industrial and public health clinics and all places where | 0022| dangerous drugs are stored, distributed, dispensed or | 0023| administered and provide for the inspection of [their] the | 0024| facilities and activities; | 0025| [G.] (7) enforce the provisions of all | 0001| laws of the state pertaining to the practice of pharmacy and | 0002| the manufacture, production, sale or distribution of drugs or | 0003| cosmetics [or poisons] and their standards of strength and | 0004| purity; | 0005| [H.] (8) conduct hearings upon charges | 0006| relating to the discipline of a registrant or licensee or the | 0007| denial, suspension or revocation of a [certificate of] | 0008| registration or a license in accordance with the Uniform | 0009| Licensing Act; | 0010| [I. provide for the institution of | 0011| proceedings concerning minor violations of the Pharmacy Act | 0012| whenever the board believes that the public interest will be | 0013| adequately served by a suitable written notice or warning or by | 0014| a suspension of registration or licensure for a period not to | 0015| exceed thirty days; | 0016| J.] (9) cause the prosecution of any person | 0017| violating the Pharmacy Act, the New Mexico Drug, Device and | 0018| Cosmetic Act or the Controlled Substances Act; | 0019| [K.] (10) keep a record of all proceedings | 0020| of the board; | 0021| [L.] (11) make an annual report to the | 0022| governor; | 0023| [M.] (12) appoint and employ, in the | 0024| board's discretion, a qualified person who is not a member of | 0025| the board to serve as executive [officer to the board] | 0001| director and define his duties and responsibilities; except | 0002| that the power to [grant] deny, revoke or suspend any license | 0003| or registration authorized by the Pharmacy Act shall not be | 0004| delegated by the board; | 0005| [N.] (13) appoint and employ inspectors | 0006| necessary to enforce the provisions of all acts under the | 0007| administration of the board, which inspectors shall be | 0008| pharmacists and have all the powers and duties of peace | 0009| officers; | 0010| [O.] (14) provide for other qualified | 0011| employees necessary to carry out the provisions of the Pharmacy | 0012| Act; | 0013| [P.] (15) have the authority to employ a | 0014| competent attorney to give advice and counsel in regard to any | 0015| matter connected with the duties of the board, to represent the | 0016| board in any legal proceedings and to aid in the enforcement of | 0017| the laws in relation to the pharmacy profession and to fix the | 0018| compensation to be paid to the attorney; provided, however, | 0019| that the attorney shall be compensated from the [funds] | 0020| money of the board, including [those] that provided for | 0021| in Section 61-11-19 NMSA 1978; | 0022| [Q. adopt, regularly review and revise rules and | 0023| regulations regarding the use of supportive personnel, | 0024| including pharmacists' supervision, duties and responsibilities | 0025| in relation to supportive personnel and requirements for | 0001| training of supportive personnel, including on-the-job | 0002| training; and] | 0003| (16) register and regulate qualifications, | 0004| training and permissible activities of pharmacy technicians; | 0005| (17) provide a registry of all persons | 0006| licensed as pharmacists or pharmacist interns in the state; | 0007| and | 0008| [R.] (18) adopt rules and regulations that | 0009| [define requirements for] prescribe the activities and | 0010| duties of pharmacy owners and pharmacists in the provision of | 0011| pharmaceutical care, drug regimen review and patient | 0012| counseling in each practice setting. | 0013| B. The board may: | 0014| (1) delegate its authority to the executive | 0015| director to issue temporary licenses as provided in Section | 0016| 61-11-14 NMSA 1978; and | 0017| (2) provide by regulation for the electronic | 0018| transmission of prescriptions." | 0019| Section 7. Section 61-11-7 NMSA 1978 (being Laws 1969, | 0020| Chapter 29, Section 6, as amended) is amended to read: | 0021| "61-11-7. DRUG DISPENSATION--LIMITATIONS.-- | 0022| A. The Pharmacy Act does not prohibit: | 0023| (1) any hospital or state or county | 0024| institution or clinic without the services of a staff | 0025| pharmacist from acquiring and having in its possession any | 0001| dangerous drug for the purpose of dispensing [provided] if | 0002| it is in a dosage form suitable for dispensing and [provided | 0003| that] if the hospital, institution or clinic employs a | 0004| consulting pharmacist; | 0005| (2) if the consulting pharmacist is not | 0006| available, the withdrawal of any drug from stock by a licensed | 0007| professional nurse on the order of a licensed practitioner in | 0008| such amount as needed for administering to and treatment of his | 0009| patient; | 0010| (3) the extemporaneous preparation by a | 0011| licensed professional nurse on the order of a licensed | 0012| practitioner of simple solutions for injection when the | 0013| solution may be prepared from a quantity of drug that has been | 0014| prepared previously by a pharmaceutical manufacturer or | 0015| pharmacist and obtained by the hospital, institution or clinic | 0016| in a form suitable for the preparation of the solution; | 0017| (4) the sale of non-narcotic, nonpoisonous or | 0018| nondangerous nonprescription medicines or preparations by | 0019| nonregistered persons or unlicensed stores when sold in their | 0020| original containers; | 0021| (5) the sale of drugs intended for veterinary | 0022| use; provided that if such drugs bear the legend: "caution: | 0023| federal law restricts this drug to use by or on the order of a | 0024| licensed veterinarian", the drug may be sold or distributed | 0025| only as provided in Subsection A of Section 26-1-15 NMSA 1978, | 0001| by a person possessing a license issued by the board [under] | 0002| pursuant to Subsection B of Section 61-11-14 NMSA 1978; | 0003| (6) the sale to or possession or | 0004| administration of topical ocular pharmaceutical agents by | 0005| licensed optometrists who have been certified by the board of | 0006| optometry for the use of such agents; | 0007| (7) the sale to or possession or | 0008| administration of oral pharmaceutical agents as authorized in | 0009| Subsection A of Section 61-2-10.2 NMSA 1978 by licensed | 0010| optometrists who have been certified by the board of optometry | 0011| for the use of such agents; [or] | 0012| (8) [supportive personnel] pharmacy | 0013| technicians from providing assistance to pharmacists; or | 0014| (9) a pharmacist from exercising his | 0015| professional judgment in refilling a prescription for a | 0016| prescription drug, unless prohibited by another state or | 0017| federal law, without the authorization of the prescribing | 0018| licensed practitioner, if: | 0019| (a) failure to refill the prescription | 0020| might result in an interruption of a therapeutic regimen or | 0021| create patient suffering; | 0022| (b) the pharmacist is unable to contact | 0023| the licensed practitioner after reasonable effort; | 0024| (c) the quantity of prescription drug | 0025| dispensed does not exceed a seventy-two-hour supply; | 0001| (d) the pharmacist informs the patient | 0002| or the patient's agent at the time of dispensing that the | 0003| refill is being provided without such authorization and that | 0004| authorization of the licensed practitioner is required for | 0005| future refills; and | 0006| (e) the pharmacist informs the licensed | 0007| practitioner of the emergency refill at the earliest reasonable | 0008| time. | 0009| B. All prescriptions requiring the preparation of | 0010| dosage forms or amounts of dangerous drugs not available in the | 0011| stock of a hospital, institution or clinic or a prescription | 0012| [necessitating] requiring compounding shall be either | 0013| compounded or dispensed only by a pharmacist." | 0014| Section 8. Section 61-11-8 NMSA 1978 (being Laws 1969, | 0015| Chapter 29, Section 7, as amended) is amended to read: | 0016| "61-11-8. DRUG RECORDS TO BE KEPT.--Records shall be kept | 0017| by all [hospitals, institutions or clinics] persons licensed | 0018| pursuant to the Pharmacy Act of all dangerous drugs, their | 0019| receipt, withdrawal from stock and use or other disposal. The | 0020| records shall be open to inspection by the board or its agents, | 0021| and [both the pharmacist in charge and the hospital, | 0022| institution or clinic] the licensee shall be responsible for | 0023| the maintenance of the records in proper form." | 0024| Section 9. Section 61-11-9 NMSA 1978 (being Laws 1969, | 0025| Chapter 29, Section 8, as amended) is amended to read: | 0001| "61-11-9. QUALIFICATIONS FOR [REGISTRATION] LICENSURE | 0002| AS A PHARMACIST BY EXAMINATION.-- | 0003| A. An applicant for [registration] licensure as | 0004| a pharmacist by examination shall: | 0005| (1) have reached the age of majority and not | 0006| be addicted to the use of drugs or [alcoholic liquors] | 0007| alcohol; | 0008| (2) be a graduate of a school or college of | 0009| pharmacy [accredited by the American council on pharmaceutical | 0010| education] approved by the board; | 0011| (3) have not less than one year of experience | 0012| under the direction of a pharmacist in accordance with the | 0013| programs of supervised training established by regulation of | 0014| the board; | 0015| (4) pass an examination [prepared and | 0016| administered] approved by the board [which examination | 0017| shall be based on the subjects and minimum grading standards as | 0018| set forth in the bylaws of the national association of boards | 0019| of pharmacy]; and | 0020| (5) pass an examination [prepared and | 0021| administered] approved by the board, which examination shall | 0022| be based on federal and state drug laws and regulations. | 0023| B. Any person who is a graduate of a foreign school | 0024| of pharmacy may be eligible for licensure as a pharmacist upon | 0025| successful completion of an equivalency examination program | 0001| [and an examination on New Mexico laws and] approved by the | 0002| board [regulations. The board shall adopt regulations that | 0003| define the content of the examinations. | 0004| C. The board shall register an applicant and issue | 0005| a]. | 0006| C. The board shall [register an applicant and] | 0007| issue a license when [his] the applicant's application has | 0008| been filed with and approved by the board [he] and the | 0009| applicant has paid the required fees and [he has passed the | 0010| required examinations] has met the requirements of this | 0011| section." | 0012| Section 10. Section 61-11-10 NMSA 1978 (being Laws 1969, | 0013| Chapter 29, Section 9) is amended to read: | 0014| "61-11-10. RECIPROCAL [REGISTRATION] LICENSURE.--The | 0015| board may issue a [certificate of registration] license, | 0016| with or without examination, to a person who: | 0017| A. is [registered] licensed as a pharmacist by | 0018| examination in another state [which] that under equivalent | 0019| conditions will grant reciprocal [registration] licensure | 0020| to persons [registered] licensed as pharmacists by | 0021| examination in this state; and | 0022| B. produces evidence satisfactory to the board that | 0023| he has the age, education, experience and qualifications | 0024| required of applicants for [registration] licensure by | 0025| examination under the provisions of the Pharmacy Act. Any | 0001| person who was registered by examination in another state prior | 0002| to May 20, 1940 is required to satisfy only those requirements | 0003| in existence in this state at the time he was registered in the | 0004| other state." | 0005| Section 11. Section 61-11-11 NMSA 1978 (being Laws 1969, | 0006| Chapter 29, Section 10) is amended to read: | 0007| "61-11-11. PHARMACIST INTERN--QUALIFICATIONS FOR | 0008| [REGISTRATION.--There is established under the board] | 0009| LICENSURE.--The classification of pharmacist intern is | 0010| established. An applicant for [registration] licensure as | 0011| a pharmacist intern shall: | 0012| A. be not less than eighteen years of age and not | 0013| be addicted to the use of drugs or alcohol; | 0014| B. have satisfactorily completed not less than | 0015| thirty semester hours or the equivalent thereof in a school | 0016| or college of pharmacy [accredited by the American council on | 0017| pharmaceutical education] approved by the board; and | 0018| C. meet other requirements established by | 0019| regulation of the board." | 0020| Section 12. A new section of the Pharmacy Act is enacted | 0021| to read: | 0022| "[NEW MATERIAL] PHARMACY TECHNICIAN--QUALIFICATIONS-- | 0023| DUTIES.-- | 0024| A. The classification of pharmacy technician is | 0025| established. An applicant for registration as a pharmacy | 0001| technician shall: | 0002| (1) be at least sixteen years of age and not | 0003| addicted to drugs or alcohol; | 0004| (2) complete initial training as required by | 0005| regulations of the board that includes on-the-job and related | 0006| education commensurate with the tasks to be performed by the | 0007| pharmacy technician; and | 0008| (3) if the potential duties of the pharmacy | 0009| technician will include the preparation of sterile products, | 0010| complete an additional one hundred hours of experiential | 0011| training as required by regulations of the board. | 0012| B. Permissible activities for pharmacy technicians | 0013| under the supervision of a pharmacist include: | 0014| (1) the preparation, mixing, assembling, | 0015| packaging and labeling of medications; | 0016| (2) processing routine orders of stock | 0017| supplies; | 0018| (3) preparation of sterile products; and | 0019| (4) filling of a prescription or medication | 0020| order that entails counting, pouring, labeling or | 0021| reconstituting medications. | 0022| C. The supervising pharmacist shall observe and | 0023| direct the pharmacy technician to a sufficient degree to assure | 0024| the accurate completion of the activities of the pharmacy | 0025| technician and shall provide a final check of all aspects of | 0001| the prepared product and document the final check before | 0002| dispensing. | 0003| D. The supervising pharmacist shall be responsible | 0004| for the tasks performed by the pharmacist technician and | 0005| subject to discipline for failure to appropriately supervise | 0006| the performance of the pharmacist technician." | 0007| Section 13. Section 61-11-12 NMSA 1978 (being Laws 1969, | 0008| Chapter 29, Section 11, as amended) is amended to read: | 0009| "61-11-12. [REGISTRATION] LICENSE FEES.-- | 0010| A. An applicant for [registration] licensure as | 0011| a pharmacist or pharmacist intern or registration as a | 0012| pharmacy technician shall pay the following fees, which fees | 0013| shall not be returnable: | 0014| (1) for [registration] initial licensure | 0015| as a pharmacist, [by examination] a fee set by the board not | 0016| to exceed [two hundred dollars ($200)] four hundred dollars | 0017| ($400); provided that if the applicant fails a portion of | 0018| [the] an examination, reexamination is subject to the same | 0019| fee as the first examination; | 0020| [(2) for registration as a pharmacist without | 0021| examination, a fee set by the board not to exceed two hundred | 0022| dollars ($200); and | 0023| (3)] (2) for [registration] initial | 0024| licensure as a pharmacist intern, a fee not to exceed twenty- | 0025| five dollars ($25.00); and | 0001| (3) for initial registration as a pharmacy | 0002| technician, a fee not to exceed twenty-five dollars ($25.00). | 0003| B. The board shall issue [an appropriate | 0004| certificate of registration or] a license [to each person | 0005| registered as a pharmacist or, pharmacist intern] or | 0006| registration to each successful applicant and enter his name | 0007| and pertinent information in the registry maintained by the | 0008| board. | 0009| C. Every [certificate of] registration or license | 0010| [of pharmacists or pharmacist interns] shall have the seal of | 0011| the board affixed and be signed by the board [secretary- | 0012| treasurer] chairman." | 0013| Section 14. Section 61-11-13 NMSA 1978 (being Laws 1969, | 0014| Chapter 29, Section 12, as amended) is amended to read: | 0015| "61-11-13. [REGISTRATION] RENEWAL--REVOCATION.-- | 0016| A. [All annual licenses for pharmacists shall | 0017| expire on June 30, and commencing July 1, 1984] The annual | 0018| renewal date for each [registrant] licensee shall be the | 0019| last day of the [registrant's] licensee's birth month. Any | 0020| person who intends to continue practice shall file an | 0021| application for renewal and pay the renewal fee set by the | 0022| board in an amount not to exceed one hundred fifty dollars | 0023| ($150) prior to that date; provided, however, the board shall | 0024| prorate any renewal fee charged for any period of less than one | 0025| year. The license of [any] a pharmacist failing to renew | 0001| his license on or before that date will automatically expire, | 0002| and it shall not be reinstated except upon reapplication and | 0003| payment of a [twenty-five dollar ($25.00)] one hundred | 0004| dollar ($100) reinstatement fee and all delinquent renewal | 0005| fees. | 0006| B. [Any] A pharmacist ceasing to be engaged in | 0007| the practice of pharmacy for such period as the board | 0008| determines, but not less than twelve months, is deemed to be | 0009| inactive and shall have his license renewal so marked. A | 0010| pharmacist having an inactive status shall not be reinstated to | 0011| active status without either an examination or the presentation | 0012| of evidence satisfactory to the board that he has taken some | 0013| form of internship or continuing education relevant to the | 0014| practice of pharmacy, or both, immediately prior to his | 0015| application for reinstatement. Pharmacists regularly engaged | 0016| in teaching in an approved school or college of pharmacy, | 0017| servicing, manufacturing, inspecting or other phases of the | 0018| pharmaceutical profession are in active status for the purposes | 0019| of this subsection. | 0020| C. Application for renewal of [pharmacists' | 0021| licenses] a pharmacist's license shall be made on forms | 0022| prescribed and furnished by the board and shall indicate | 0023| whether the renewal applied for will be an active or inactive | 0024| [registration] license. The application, together with the | 0025| renewal fee, shall be filed with the board. | 0001| D. Application for renewal of [pharmacists' | 0002| licenses] a pharmacist's license shall be accompanied by | 0003| proof satisfactory to the board that the applicant has | 0004| completed continuing education requirements established | 0005| pursuant to Section 61-11-6 NMSA 1978. | 0006| E. [Applications] An application for renewal of | 0007| a certificate of registration as a pharmacy technician or | 0008| license as a pharmacist intern shall be filed with the board | 0009| on forms prescribed and furnished by the board and shall be | 0010| accompanied by a renewal fee not to exceed twenty-five dollars | 0011| ($25.00) per year." | 0012| Section 15. Section 61-11-14 NMSA 1978 (being Laws 1969, | 0013| Chapter 29, Section 13, as amended) is amended to read: | 0014| "61-11-14. PHARMACY LICENSURE--WHOLESALE DRUG | 0015| DISTRIBUTION BUSINESS LICENSURE--REQUIREMENTS--FEES-- | 0016| REVOCATION.-- | 0017| A. Any person who desires to operate or maintain | 0018| the operation of a pharmacy or who engages in a wholesale drug | 0019| distribution business in this state shall apply to the board | 0020| for the proper [permit or] license and shall meet the | 0021| requirements of the board and pay the annual fee for the | 0022| [permit or] license and its renewal. | 0023| B. The board shall issue the following classes of | 0024| [permits or] licenses that shall be defined and limited by | 0025| regulation of the board: | 0001| (1) retail pharmacy [license]; | 0002| (2) nonresident pharmacy [license]; | 0003| (3) wholesale drug [distributor's license] | 0004| distributor; | 0005| (4) drug [manufacturer's license] | 0006| manufacturer; | 0007| (5) hospital pharmacy; [license for both | 0008| inpatient and outpatient dispensing; | 0009| (6) drug room license; | 0010| (7) drug custodial license for licensed | 0011| nursing homes; | 0012| (8) state license for the department of | 0013| health; | 0014| (9) drug permit for] (6) pharmaceutical | 0015| sales [representatives who possess dangerous drugs] | 0016| representative; | 0017| [(10) limited drug permit for industrial and | 0018| public health clinics not under the department of health and | 0019| businesses of a similar nature where dangerous drugs are | 0020| dispensed, the permit being limited to specific dangerous drugs | 0021| or other limitations as set forth in the application and shown | 0022| on the permit,] | 0023| (7) industrial health clinic; | 0024| (8) public health clinic; | 0025| (9) custodial care facility; | 0001| [(11) limited drug permit for] (10) home | 0002| care services [not under the department of health in which | 0003| dangerous drugs are stored and administered, the permit being | 0004| limited to specific dangerous drugs or other limitations as set | 0005| forth in the board's regulations and shown on the permit; and | 0006| (12) limited license for wholesalers, | 0007| retailers or distributors]; | 0008| (11) emergency medical services; | 0009| (12) animal control facilities; and | 0010| (13) wholesaler, retailer or distributor of | 0011| veterinary drugs bearing the legend: "caution: federal law | 0012| restricts this drug to use by or on the order of a licensed | 0013| veterinarian". Such drugs may be sold or dispensed by any | 0014| person possessing a retail pharmacy license, wholesale drug | 0015| distributor's license or drug manufacturer's license issued by | 0016| the board, without the necessity of acquiring [a limited] an | 0017| additional license for veterinary drugs [as provided in this | 0018| paragraph]. | 0019| C. Every application for the issuance or annual | 0020| renewal of: | 0021| (1) a license for a retail pharmacy, wholesale | 0022| drug distributor, nonresident pharmacy, pharmaceutical sales | 0023| representative, drug manufacturer or hospital pharmacy shall be | 0024| accompanied by a fee set by the board in an amount not to | 0025| exceed three hundred dollars ($300); | 0001| (2) a license [or permit for a drug room or a | 0002| nursing home] for a custodial care facility shall be | 0003| accompanied by a fee set by the board in an amount not to | 0004| exceed [one hundred dollars ($100)] two hundred dollars | 0005| ($200); and | 0006| (3) a license [or a permit] for an | 0007| industrial [or] health clinic; a public health clinic; [or | 0008| a business of a similar nature, a limited drug permit issued | 0009| pursuant to the provisions of Paragraph (11) of Subsection B of | 0010| this section or a limited license issued pursuant to Paragraph | 0011| (12) of Subsection B of this section] home care services; | 0012| emergency medical services; animal control facilities; or | 0013| wholesaler, retailer or distributor of veterinary drugs shall | 0014| be accompanied by a fee set by the board in an amount not to | 0015| exceed two hundred dollars ($200) [and | 0016| (4) the department of health license shall be | 0017| accompanied by a fee set by the board in an aggregate amount | 0018| based on a charge not to exceed two hundred dollars ($200) for | 0019| each facility where dangerous drugs are stored and dispensed or | 0020| distributed; provided that the charge for each facility shall | 0021| in no instance be more than the fee set for industrial or | 0022| public health clinics]. | 0023| D. If it is desired to operate or maintain a | 0024| pharmaceutical business at more than one location, a separate | 0025| license [or permit] shall be obtained for each location. | 0001| E. Each application for a [permit or] license | 0002| shall be made on forms prescribed and furnished by the board. | 0003| F. Any person making application to the board for a | 0004| license to operate a new retail pharmacy, hospital pharmacy, | 0005| wholesale drug [business] distributor or drug | 0006| [manufacturing business] manufacturer in this state shall | 0007| submit to the board an application for licensure indicating: | 0008| (1) the name under which the business is to be | 0009| operated; | 0010| (2) the address of each location to be | 0011| licensed and the address of the principal office of the | 0012| business; | 0013| (3) in the case of a retail pharmacy, the name | 0014| and address of the owner, partner or officer or director of a | 0015| corporate owner; | 0016| (4) the type of business to be conducted at | 0017| each location; | 0018| (5) a rough drawing of the floor plan of each | 0019| location to be licensed; | 0020| (6) the proposed days and hours of operation | 0021| of the business; and | 0022| (7) other information the board may require. | 0023| G. After preliminary approval of the application | 0024| for a license for a retail pharmacy, a hospital pharmacy, a | 0025| drug [manufacturing business] manufacturer or a wholesale | 0001| drug [distribution business] distributor, a request for an | 0002| inspection, together with an inspection fee not to exceed two | 0003| hundred dollars ($200), shall be submitted to the board for | 0004| each business location, and an inspection shall be made of each | 0005| location by the board or its agent. | 0006| H. Following a deficiency-free inspection, the | 0007| executive director of the board may issue a temporary license | 0008| to the applicant. The temporary license shall expire at the | 0009| close of business on the last day of the next regular board | 0010| meeting. | 0011| [G.] I. Licenses [and permits] issued by the | 0012| board [under] pursuant to this section are not transferable | 0013| and shall expire on December 31 of each year unless renewed. | 0014| Any person failing to renew his license [or permit] on or | 0015| before December 31 of each year shall not have his license [or | 0016| permit] reinstated except upon reapplication and payment of | 0017| a reinstatement fee set by the board in an amount not to exceed | 0018| one hundred dollars ($100) and all delinquent renewal fees. | 0019| [H.] J. The board, after notice and a refusal | 0020| or failure to comply, [is authorized to] may suspend or | 0021| revoke any license [or permit] issued under the provisions of | 0022| the Pharmacy Act at any time examination or inspection of the | 0023| operation for which the license [or permit] was granted | 0024| discloses that [such place] the operation is not being | 0025| conducted according to law or regulations of the board." | 0001| Section 16. Section 61-11-14.1 NMSA 1978 (being Laws | 0002| 1992, Chapter 19, Section 7) is amended to read: | 0003| "61-11-14.1. NONRESIDENT PHARMACY LICENSURE--TOLL-FREE | 0004| TELEPHONE SERVICE.-- | 0005| A. Any person making application to the board for a | 0006| nonresident pharmacy license shall submit to the board an | 0007| application for licensure that discloses the following | 0008| information: | 0009| (1) the address of the principal office of the | 0010| nonresident pharmacy and the names and titles of all principal | 0011| corporate officers and all pharmacists who are dispensing | 0012| controlled substances or dangerous drugs to residents of this | 0013| state. A report containing this information shall be made on | 0014| an annual basis and within thirty days after any change of | 0015| office location, corporate officer or pharmacist in charge; | 0016| (2) that the nonresident pharmacy complies | 0017| with all lawful directions and requests for information from | 0018| the regulatory or licensing agency of the state in which it is | 0019| a resident, as well as with requests for information made by | 0020| the board pursuant to this section; | 0021| (3) that the nonresident pharmacy maintains, | 0022| at all times, a valid license, permit or registration to | 0023| operate the pharmacy in compliance with the laws of the state | 0024| in which it is a resident; | 0025| (4) a copy of the most recent inspection | 0001| report resulting from an inspection of the nonresident pharmacy | 0002| conducted by the regulatory or licensing agency of the state in | 0003| which it is a resident; and | 0004| (5) that the nonresident pharmacy maintains | 0005| its records of controlled substances or dangerous drugs that | 0006| are dispensed to patients in this state so that the records are | 0007| readily retrievable. | 0008| B. A nonresident pharmacy licensed under this | 0009| section shall provide a toll-free telephone service to | 0010| facilitate communication between patients in this state and a | 0011| pharmacist at the nonresident pharmacy who has access to the | 0012| patient's records. A nonresident pharmacy shall provide the | 0013| toll-free telephone service during its regular hours of | 0014| operation, but not less than six days a week and for a minimum | 0015| of forty hours a week. The toll-free telephone number shall be | 0016| disclosed on a label affixed to each container of drugs | 0017| dispensed to patients in this state. | 0018| [C. Nothing in this section shall be construed to | 0019| authorize the dispensing of contact lenses by nonresident | 0020| pharmacies.]" | 0021| Section 17. Section 61-11-15 NMSA 1978 (being Laws 1969, | 0022| Chapter 29, Section 14, as amended) is amended to read: | 0023| "61-11-15. PHARMACIES--SALE OF DRUGS--SUPERVISION | 0024| REQUIREMENTS.-- | 0025| A. No owner [or proprietor] of a pharmacy | 0001| shall: | 0002| [A.] (1) fail to place a pharmacist in | 0003| charge; [of the pharmacy; provided that this restriction shall | 0004| not apply to any person possessing only a limited license | 0005| issued under Subsection B of Section 67-9-45 NMSA 1953; | 0006| B.] (2) intentionally or fraudulently | 0007| adulterate or cause to be adulterated or misbrand or cause to | 0008| be misbranded any drugs compounded, sold or offered for sale in | 0009| the pharmacy; | 0010| [C.] (3) by himself or through any other | 0011| person, permit the compounding of prescriptions or the selling | 0012| of dangerous drugs [or poisons] in his place of business | 0013| except by a pharmacist, [or a] pharmacist intern or pharmacy | 0014| technician; | 0015| [D.] (4) by himself or through any other | 0016| person, sell, offer for sale, compound or dispense dangerous | 0017| drugs [or poisons] without being a pharmacist, pharmacist | 0018| intern or pharmacy technician; provided that veterinary drugs | 0019| bearing the legend: "caution: federal law restricts this drug | 0020| to use by or on the order of a licensed veterinarian" may be | 0021| sold, offered for sale or distributed by persons holding a | 0022| [limited] license issued [under] pursuant to Subsection B | 0023| of Section [67-9-45 NMSA 1953] 61-11-14 NMSA 1978; or | 0024| [E.] (5) operate a pharmacy without the | 0025| appropriate license. | 0001| B. Whenever an applicable law, rule or regulation | 0002| requires or prohibits action by a pharmacy, responsibility for | 0003| the violation shall be that of the owner and the pharmacist in | 0004| charge." | 0005| Section 18. Section 61-11-16 NMSA 1978 (being Laws 1969, | 0006| Chapter 29, Section 15) is amended to read: | 0007| "61-11-16. PHARMACIES--EQUIPMENT REQUIRED.--There shall | 0008| be kept in every pharmacy, subject to review or testing by | 0009| the board or its authorized agents, [modern prescription | 0010| balances with weights, the necessary graduates, mortars and | 0011| pestles, all in good condition, for compounding prescriptions, | 0012| and] such [books] references and [other] equipment as | 0013| the board may | 0014| designate by regulation." | 0015| Section 19. Section 61-11-17 NMSA 1978 (being Laws 1969, | 0016| Chapter 29, Section 16) is amended to read: | 0017| "61-11-17. DISPLAY OF LICENSE.--[PERMIT OR CERTIFICATE.- | 0018| -The pharmacist in charge of a pharmacy, a pharmacist or a | 0019| pharmacist intern, and the owner of a pharmacy or other | 0020| pharmaceutical business shall cause their current certificate | 0021| of] Every person shall have his license or registration [or | 0022| their current permit or] and the license for the operation | 0023| of the business [to be] conspicuously displayed in the | 0024| pharmacy or place of business to which it applies or in which | 0025| [they are] he is employed. [Failure to display a | 0001| certificate of registration or a license or permit shall cause | 0002| the certificate license or permit to be suspended until the | 0003| provisions of Section 13 of the Pharmacy Act are complied with | 0004| and the certificate license or permit is properly displayed.]" | 0005| Section 20. Section 61-11-18 NMSA 1978 (being Laws 1969, | 0006| Chapter 29, Section 17, as amended) is amended to read: | 0007| "61-11-18. STATE LICENSE--ACTIONS AUTHORIZED.--The board | 0008| shall [issue one] license [to the] department of health | 0009| [and environment department of the state to cover all of its] | 0010| clinics and other health facilities of the department where | 0011| dangerous drugs are stored, distributed or dispensed. All such | 0012| clinics or other health facilities of the department are | 0013| subject to the provisions of the Pharmacy Act [must keep | 0014| records of all dangerous drugs and may be inspected by the | 0015| board or its agents at any reasonable time. The license shall | 0016| permit the health and environment department to: | 0017| A. acquire, possess, store and repackage dangerous | 0018| drugs for distribution to its clinics and other health | 0019| facilities, provided it is done under procedures developed by a | 0020| staff pharmacist of the department charged with the | 0021| responsibility for the distribution and accountability of the | 0022| drugs and the procedures are approved by the board; | 0023| B. receive, possess and store dangerous drugs in | 0024| any clinic or other health facility of the health and | 0025| environment department for use in any public health program; | 0001| and | 0002| C. dispense dangerous drugs in furtherance of any | 0003| public health program under the supervision of a pharmacist, a | 0004| consulting pharmacist or a licensed practitioner]." | 0005| Section 21. A new section of the Pharmacy Act is enacted | 0006| to read: | 0007| "[NEW MATERIAL] REPORTS TO BOARD.--A licensee shall | 0008| report in writing the occurrence of any of the following events | 0009| to the board within thirty days of discovery: | 0010| A. permanent closing of a licensed premises; | 0011| B. change of ownership, management, location or | 0012| pharmacist in charge; | 0013| C. theft or loss of drugs or devices; | 0014| D. conviction of an employee for violating any | 0015| federal or state drug laws; | 0016| E. theft, destruction or loss of records required | 0017| by federal or state law to be maintained; | 0018| F. occurrences of significant adverse drug | 0019| reactions, as defined by regulations of the board; | 0020| G. dissemination of confidential information or | 0021| personally identifiable information to a person other than a | 0022| person authorized by the provisions of the Pharmacy Act or | 0023| regulations adopted pursuant to that act to receive such | 0024| information; and | 0025| H. other matters or occurrences as the board may | 0001| require by regulation." | 0002| Section 22. Section 61-11-20 NMSA 1978 (being Laws 1969, | 0003| Chapter 29, Section 19, as amended) is amended to read: | 0004| "61-11-20. DISCIPLINARY PROCEEDINGS--UNIFORM LICENSING | 0005| ACT.-- | 0006| A. In accordance with the Uniform Licensing Act, | 0007| the board may deny, withhold, suspend or revoke any | 0008| [certificate of] registration or license held or applied for | 0009| under the Pharmacy Act upon grounds that the licensee or | 0010| applicant: | 0011| (1) is guilty of gross immorality or | 0012| dishonorable or unprofessional conduct as defined by regulation | 0013| of the board; | 0014| (2) is convicted of a violation of any federal | 0015| law relating to controlled substances, any federal food and | 0016| drug law or any federal law requiring the maintenance of drug | 0017| records; | 0018| (3) is guilty of a violation of the Controlled | 0019| Substances Act, the Pharmacy Act or the New Mexico Drug, | 0020| Device and Cosmetic Act; | 0021| (4) is addicted to the use of dangerous drugs | 0022| or narcotic drugs of any kind; | 0023| (5) is habitually intemperate; | 0024| (6) is guilty of knowingly or fraudulently | 0025| adulterating or misbranding or causing to be adulterated or | 0001| misbranded any drugs; | 0002| (7) is guilty of procuring or attempting to | 0003| procure [registration] licensure as a pharmacist or | 0004| pharmacist intern, registration as a pharmacy technician or | 0005| licensure for a pharmacy or pharmaceutical business in this | 0006| state for himself or another by knowingly making or causing to | 0007| be made false representations to the board; | 0008| (8) is unfit or unable to practice pharmacy by | 0009| reason of a physical or mental disease or disability as | 0010| determined by the board and based on competent medical | 0011| authority, during the period of such disability; [or] | 0012| (9) fails to maintain any drug records | 0013| required by any federal law resulting in the condemnation of | 0014| any drugs in his possession or control; | 0015| (10) is convicted of any felony; | 0016| (11) has furnished false or fraudulent | 0017| material in any application made in connection with drug or | 0018| device manufacturing or distribution; | 0019| (12) has had any drug manufacturer or | 0020| wholesale drug distributor license suspended or revoked; | 0021| (13) has obtained any remuneration for | 0022| professional services by fraud, misrepresentation or deception; | 0023| (14) has dealt with drugs or devices that he | 0024| knew or should have known were stolen; | 0025| (15) has purchased or received a drug or | 0001| device from a source other than a person or pharmacy licensed | 0002| pursuant to the Pharmacy Act, unless otherwise provided in that | 0003| act, the Controlled Substances Act or the New Mexico Drug, | 0004| Device and Cosmetic Act; | 0005| (16) is a wholesale drug distributor other | 0006| than a pharmacy and dispenses or distributes drugs or devices | 0007| directly to a patient; | 0008| (17) has violated any rule or regulation | 0009| adopted by the board pursuant to the Pharmacy Act; or | 0010| (18) has divulged or revealed confidential | 0011| information or personally identifiable information to a person | 0012| other than a person authorized by the provisions of the | 0013| Pharmacy Act or regulations adopted pursuant to that act to | 0014| receive such information. | 0015| B. Disciplinary proceedings may be instituted by | 0016| any person, shall be by sworn complaint and shall conform with | 0017| the provisions of the Uniform Licensing Act. Any party to the | 0018| hearing may obtain a copy of the hearing record upon payment of | 0019| costs for the copy. | 0020| C. The board may modify any prior order of | 0021| revocation, suspension or refusal to issue a license [or | 0022| certificate of registration] of a pharmacist or a pharmacist | 0023| intern or registration of a pharmacy technician but only upon | 0024| a finding by the board that there no longer exist any grounds | 0025| for disciplinary action; provided that any cessation of the | 0001| practice of pharmacy for twelve months or more shall require | 0002| the pharmacist to undergo additional education, internship or | 0003| examination as the board determines necessary. | 0004| [D. Nothing in the Pharmacy Act shall be construed | 0005| as requiring the board to report, for the institution of | 0006| proceedings, minor violations of the Pharmacy Act whenever the | 0007| board believes that the public interest will be adequately | 0008| served by a suitable written notice or warning or by a | 0009| suspension of a certificate of registration, license or permit | 0010| for a period not to exceed thirty days after an informal | 0011| hearing.]" | 0012| Section 23. Section 61-11-21 NMSA 1978 (being Laws 1969, | 0013| Chapter 29, Section 20, as amended) is amended to read: | 0014| "61-11-21. LICENSING OF PHARMACISTS AND PHARMACIES | 0015| REQUIRED.-- | 0016| A. Unless he is a pharmacist or is exempted under | 0017| the Pharmacy Act, no person shall sell at retail any dangerous | 0018| drug [or poison], compound any prescription or acquire and | 0019| possess any dangerous drug without its being prescribed. | 0020| B. No person shall conduct or operate a place used | 0021| for the retail sale, compounding or dispensing of drugs or | 0022| prescriptions or a place represented by a sign or by | 0023| advertisement to have a business name or specialization that | 0024| includes the words "pharmacist", "pharmacy", "apothecary", | 0025| "apothecary shop", "chemist's shop", "drug store", "drugs", | 0001| "druggist", "drug sundries", "prescriptions" or any combination | 0002| [thereof] of these or any other words of similar import or | 0003| by an insignia or device that might indicate to the public that | 0004| the place is a pharmacy unless [(1)] the place is licensed by | 0005| the board under the Pharmacy Act [and | 0006| (2) the business being conducted on the | 0007| licensed premises constantly employs, on a regular basis, a | 0008| pharmacist]. | 0009| C. No person shall permit anyone in his employ or | 0010| under his supervision, except a pharmacist [or a], pharmacist | 0011| intern or pharmacy technician, to compound, dispense, label | 0012| or otherwise prepare prescriptions. | 0013| D. The provisions of Subsections A, B and C of this | 0014| section shall not apply to a person possessing a [limited] | 0015| license issued [under] pursuant to Subsection B of Section | 0016| [67-9-45 NMSA 1953] 61-11-14 NMSA 1978 for the sale or | 0017| distribution of veterinary drugs bearing the legend: "caution: | 0018| federal law restricts this drug to use by or on the order of a | 0019| licensed veterinarian"; provided that the possessors of such a | 0020| license may only sell or distribute such drugs on the order of | 0021| a licensed veterinarian and may not represent their place of | 0022| business by a sign or advertisement that includes the words | 0023| "pharmacist", "pharmacy", "apothecary", "apothecary shop", | 0024| "chemist's shop", "drug store", "drugs", "druggist", "drug | 0025| sundries", "prescriptions" or any combination [thereof] of | 0001| these or any words of similar import or by an insignia or | 0002| device that might indicate to the public that the place is a | 0003| pharmacy." | 0004| Section 24. Section 61-11-22 NMSA 1978 (being Laws 1969, | 0005| Chapter 29, Section 21) is amended to read: | 0006| "61-11-22. EXEMPTIONS FROM ACT.-- | 0007| A. The Pharmacy Act does not apply to licensed | 0008| practitioners in this state in supplying to their patients any | 0009| drug if the licensed practitioner is practicing his profession | 0010| and does not keep a pharmacy, advertised or otherwise, for the | 0011| retailing of dangerous drugs [or poisons]. | 0012| B. The Pharmacy Act does not prevent: | 0013| (1) the personal administration of drugs | 0014| carried by a licensed practitioner in order to supply the | 0015| immediate needs of his patients; or | 0016| (2) the sale of non-narcotic proprietary | 0017| preparations." | 0018| Section 25. Section 61-11-23 NMSA 1978 (being Laws 1969, | 0019| Chapter 29, Section 22, as amended) is amended to read: | 0020| "61-11-23. CONSTRUCTION OF LAWS RELATING TO DRUGS.-- | 0021| A. The Pharmacy Act does not amend or repeal any of | 0022| the laws [which] that govern the manufacture, sale or | 0023| distribution of controlled substances. | 0024| [B. The Pharmacy Act does not prevent or apply to | 0025| the sale or use of economic poisons as defined under the New | 0001| Mexico Economic Poisons Act of 1951. | 0002| C.] B. The Pharmacy Act does not amend or repeal | 0003| the New Mexico Drug, Device and Cosmetic Act." | 0004| Section 26. Section 61-11-24 NMSA 1978 (being Laws 1969, | 0005| Chapter 29, Section 23, as amended) is amended to read: | 0006| "61-11-24. VIOLATIONS--PENALTIES.-- | 0007| A. It is a [petty] misdemeanor for any person | 0008| to: | 0009| [A.] (1) practice or attempt to practice | 0010| pharmacy without a [certificate of registration and a] | 0011| current license from the board; | 0012| [B.] (2) use the title of [a] registered | 0013| pharmacist unless he is licensed as such [under] pursuant | 0014| to the Pharmacy Act; | 0015| [C.] (3) procure or attempt to procure | 0016| [registration] licensure as a pharmacist or to procure a | 0017| license for a pharmacy for himself or another by making or | 0018| causing to be made false representations to the board; | 0019| [D.] (4) allow any other person in his | 0020| employ or under his supervision to compound or dispense | 0021| prescriptions [or sell or compound poisons] unless he is a | 0022| pharmacist, [or registered as a] pharmacist intern or | 0023| pharmacy technician in accordance with the Pharmacy Act or | 0024| exempted [under] from the provisions of [the] that act; | 0025| or | 0001| [E.] (5) own, operate or maintain a | 0002| pharmacy, hospital pharmacy, clinic, custodial care facility or | 0003| drug distribution business unless licensed to do so [under] | 0004| pursuant to the Pharmacy Act. | 0005| B. A person convicted pursuant to Subsection A of | 0006| this section shall be sentenced pursuant to the provisions of | 0007| Section 31-19-1 NMSA 1978." | 0008| Section 27. Section 61-11-25 NMSA 1978 (being Laws 1969, | 0009| Chapter 29, Section 24) is amended to read: | 0010| "61-11-25. POWER TO ENJOIN VIOLATIONS.--In addition to | 0011| the remedies provided in the Pharmacy Act, the board [of | 0012| pharmacy is hereby authorized to] may apply to the district | 0013| court for [and such court shall have jurisdiction upon hearing | 0014| and for good cause shown to grant] a temporary or permanent | 0015| injunction restraining any person from violating any provision | 0016| of the Pharmacy Act irrespective of whether or not there exists | 0017| an adequate remedy at law." | 0018| Section 28. Section 61-11-27 NMSA 1978 (being Laws 1969, | 0019| Chapter 29, Section 26) is amended to read: | 0020| "61-11-27. TRANSFER OF FUNDS.--All [funds which have] | 0021| money that has accumulated to the credit of the board under | 0022| any previous law shall be continued for use by the board in the | 0023| administration of the Pharmacy Act and any other laws being | 0024| administered by the board." | 0025| Section 29. Section 61-11-28 NMSA 1978 (being Laws 1969, | 0001| Chapter 29, Section 28) is amended to read: | 0002| "61-11-28. UNIFORM LICENSING ACT.--The board [of | 0003| Pharmacy shall be] is subject to all the provisions of the | 0004| Uniform Licensing Act." | 0005| Section 30. Section 61-11-29 NMSA 1978 (being Laws 1979, | 0006| Chapter 266, Section 2, as amended) is amended to read: | 0007| "61-11-29. TERMINATION OF AGENCY LIFE--DELAYED REPEAL.-- | 0008| The board of pharmacy is terminated on July 1, [1997] 2003 | 0009| pursuant to the Sunset Act. The board shall continue to | 0010| operate according to the provisions of Chapter 61, Article 11 | 0011| NMSA 1978 until July 1, [1998] 2004. Effective July 1, | 0012| [1998 Article 11 of] 2004, Chapter 61, Article 11 NMSA | 0013| 1978 is repealed." | 0014| Section 31. TEMPORARY PROVISION--PHARMACY BOARD EXEMPT | 0015| FROM AUTHORITY OF REGULATION AND LICENSING DEPARTMENT.-- | 0016| A. The pharmacy board is not administratively | 0017| attached to the regulation and licensing department. Executive | 0018| Order 86-10 issued pursuant to legislative authority provided | 0019| in Laws 1983, Chapter 297, Section 30 is void as it pertains to | 0020| the control and supervision of the pharmacy board by the | 0021| regulation and licensing department. | 0022| B. On the effective date of this act, all money, | 0023| records, supplies, equipment, furniture and other personal | 0024| property belonging to the pharmacy board that is held by the | 0025| regulation and licensing department shall be transferred to the | 0001| pharmacy board. | 0002|  | 0003| State of New Mexico | 0004| House of Representatives | 0005| | 0006| FORTY-THIRD LEGISLATURE | 0007| FIRST SESSION, 1997 | 0008| | 0009| | 0010| February 4, 1997 | 0011| | 0012| | 0013| Mr. Speaker: | 0014| | 0015| Your CONSUMER AND PUBLIC AFFAIRS COMMITTEE, to | 0016| whom has been referred | 0017| | 0018| HOUSE BILL 84 | 0019| | 0020| has had it under consideration and reports same with | 0021| recommendation that it DO PASS, amended as follows: | 0022| | 0023| 1. On page 3, line 1, before the semicolon insert "as a | 0024| result of an order of a licensed practitioner". | 0025| | 0001| 2. On page 3, line 11, after "prescription" strike the | 0002| remainder of the line and strike all of line 12. | 0003| | 0004| 3. On page 3, line 19, after "patient's" insert "pharmacy". | 0005| | 0006| 4. On page 3, line 21, strike "that is privileged". | 0007| | 0008| 5. On page 3, line 23, after "professionals" insert | 0009| "as defined by regulation of the board". | 0010| | 0011| 6. On page 3, line 24, after "when" strike the line through | 0012| the comma. | 0013| | 0014| 7. On page 3, line 25, after the semicolon strike "and" and | 0015| insert in lieu thereof "or". | 0016| | 0017| 8. On page 5, line 17, strike "interpretation,". | 0018| | 0019| 9. On page 9, line 7, after "services" insert "related to | 0020| drug therapy". | 0021| | 0022| 10. On page 10, line 18, strike "interpretation,". | 0023| | 0024| 11. On page 10, line 20, after "selection" strike the first | 0025| comma and insert in lieu thereof "or". | 0001| | 0002| 12. On page 10, line 20, before the comma at the end of the | 0003| line insert "that has been ordered by a licensed practitioner". , | 0004| | 0005| | 0006| | 0007| and thence referred to the JUDICIARY COMMITTEE. | 0008| | 0009| Respectfully submitted, | 0010| | 0011| | 0012| | 0013| | 0014| | 0015| Gary K. King, Chairman | 0016| | 0017| | 0018| Adopted Not Adopted | 0019| | 0020| (Chief Clerk) (Chief Clerk) | 0021| | 0022| Date | 0023| | 0024| The roll call vote was 9 For 0 Against | 0025| Yes: 9 | 0001| Excused: Vigil | 0002| Absent: None | 0003| | 0004| | 0005| 115707.1 | 0006| G:\BILLTEXT\BILLW_97\H0084 State of New Mexico | 0007| House of Representatives | 0008| | 0009| FORTY-THIRD LEGISLATURE | 0010| FIRST SESSION, 1997 | 0011| | 0012| | 0013| February 15, 1997 | 0014| | 0015| | 0016| Mr. Speaker: | 0017| | 0018| Your JUDICIARY COMMITTEE, to whom has been referred | 0019| | 0020| HOUSE BILL 84 | 0021| | 0022| has had it under consideration and reports same with | 0023| recommendation that it DO PASS, amended as follows: | 0024| | 0025| 1. On page 37, lines 11 through 13, strike the brackets | 0001| and line through. | 0002| | 0003| Respectfully submitted, | 0004| | 0005| | 0006| | 0007| | 0008| | 0009| Thomas P. Foy, Chairman | 0010| | 0011| | 0012| Adopted Not Adopted | 0013| | 0014| (Chief Clerk) (Chief Clerk) | 0015| | 0016| Date | 0017| | 0018| The roll call vote was 9 For 0 Against | 0019| Yes: 9 | 0020| Excused: Carpenter, Luna, Mallory, Rios | 0021| Absent: None | 0022| | 0023| | 0024| .116647.1 | 0025| G:\BILLTEXT\BILLW_97\H0084 FORTY-THIRD LEGISLATURE | 0001| FIRST SESSION | 0002| | 0003| | 0004| February 16, 1997 | 0005| | 0006| | 0007| HOUSE FLOOR AMENDMENT number ___2___ to HOUSE BILL 84, as amended | 0008| | 0009| Amendment sponsored by Representative Gary K. King | 0010| | 0011| 1. On pages 49 and 50, strike Section 31 in its entirety. | 0012| | 0013| | 0014| | 0015| | 0016| | 0017| | 0018| | 0019| | 0020| | 0021| | 0022| ___________________________ | 0023| Gary K. King | 0024| | 0025| | 0001| | 0002| Adopted _________________ Not Adopted __________________________ | 0003| (Chief Clerk) (Chief Clerk) | 0004| | 0005| | 0006| Date ________________ FORTY-THIRD LEGISLATURE | 0007| FIRST SESSION | 0008| | 0009| February 18, 1997 | 0010| | 0011| HOUSE FLOOR AMENDMENT number ___1___ to HOUSE BILL 84, as amended | 0012| | 0013| Amendment sponsored by Representative Gary K. King | 0014| | 0015| | 0016| 1. Strike House Consumer and Public Affairs Committee amendment | 0017| 6. | 0018| | 0019| 2. On page 3, line 22, after "or" strike the comma and after | 0020| "directs" strike the comma and insert "; or". | 0021| | 0022| 3. On page 31, strike lines 11 and 12. | 0023| | 0024| 4. Renumber the succeeding paragraphs accordingly. | 0025| | 0001| 5. On page 32, lines 18 and 19, strike "pharmaceutical sales | 0002| representative,". | 0003| | 0004| 6. On page 35, line 18, strike the quotation marks and between | 0005| lines 18 and 19, insert: | 0006| | 0007| "K. Pharmaceutical sales representatives who carry dangerous | 0008| drugs shall register with the board. The board may charge a fee not to | 0009| exceed fifty dollars ($50.00) for registration and annual renewal. | 0010| Pharmaceutical sales representatives are not subject to the licensing | 0011| provisions of the Pharmacy Act."". | 0012| | 0013| | 0014| | 0015| ___________________________ | 0016| Gary K. King | 0017| | 0018| | 0019| | 0020| Adopted ___________________ Not Adopted ___________________________ | 0021| (Chief Clerk) (Chief Clerk) | 0022| | 0023| | 0024| Date ________________ | 0025| | 0001| | 0002| | 0003| | 0004| | 0005| | 0006| FORTY-THIRD LEGISLATURE | 0007| FIRST SESSION, 1997 | 0008| | 0009| | 0010| February 19, 1997 | 0011| | 0012| HOUSE FLOOR AMENDMENT number 3 to | 0013| HOUSE BILL 84, as amended | 0014| | 0015| Amendment sponsored by Representative Max Coll | 0016| | 0017| 1. On page 49 strike lines 16 through 23. | 0018| | 0019| 2. Renumber succeeding sections accordingly. | 0020| | 0021| Respectfully submitted, | 0022| | 0023| | 0024| | 0025| | 0001| Max Coll | 0002| | 0003| | 0004| Adopted ___________________ Not Adopted____________________ | 0005| (Chief Clerk) (Chief Clerk) | 0006| | 0007| Date _________________ | 0008| | 0009| | 0010| | 0011| G:\BILLTEXT\BILLW_97\H0084 FORTY-THIRD LEGISLATURE | 0012| FIRST SESSION, 1997 HB 84/a | 0013| | 0014| | 0015| March 15, 1997 | 0016| Mr. President: | 0017| | 0018| Your PUBLIC AFFAIRS COMMITTEE, to whom has been referred | 0019| | 0020| HOUSE BILL 84, as amended | 0021| | 0022| has had it under consideration and reports same with recommendation | 0023| that it DO PASS, amended as follows: | 0024| | 0025| 1. On page 31, line 20, strike "public" and insert in lieu | 0001| thereof "community". | 0002| | 0003| 2. On page 31, between lines 20 and 21, insert a new paragraph: | 0004| | 0005| "(9) department of health public health offices;". | 0006| | 0007| 3. Renumber succeeding paragraphs accordingly. | 0008| | 0009| 4. On page 33, line 2, strike "public" and insert in lieu thereof | 0010| "community" and after the second semicolon insert "a department of | 0011| health public health office;"., | 0012| | 0013| and thence referred to the CORPORATIONS & TRANSPORTATION | 0014| COMMITTEE. | 0015| | 0016| Respectfully submitted, | 0017| | 0018| | 0019| __________________________________ | 0020| Shannon Robinson, Chairman | 0021| | 0022| Adopted_______________________ Not Adopted_______________________ | 0023| (Chief Clerk) (Chief Clerk) | 0024| | 0025| Date ________________________ | 0001| | 0002| The roll call vote was 6 For 0 Against | 0003| Yes: 6 | 0004| No: 0 | 0005| Excused: Garcia, Ingle, Vernon | 0006| Absent: None | 0007| | 0008| | 0009| H0084PA1 .117802.1 | 0010| | 0011| | 0012| | 0013| | 0014| | 0015| FORTY-THIRD LEGISLATURE | 0016| FIRST SESSION, 1997 HB 84/a | 0017| | 0018| | 0019| March 19, 1997 | 0020| | 0021| Mr. President: | 0022| | 0023| Your CORPORATIONS & TRANSPORTATION COMMITTEE, to whom | 0024| has been referred | 0025| | 0001| HOUSE BILL 84, as amended | 0002| | 0003| has had it under consideration and reports same with recommendation | 0004| that it DO PASS, amended as follows: | 0005| | 0006| 1. On page 26, line 5, strike "sixteen" and insert in lieu | 0007| thereof, "eighteen". | 0008| | 0009| 2. On page 40, line 24, strike "thirty" and insert in lieu | 0010| thereof "fifteen". | 0011| | 0012| | 0013| Respectfully submitted, | 0014| | 0015| | 0016| | 0017| __________________________________ | 0018| Roman M. Maes, III, Chairman | 0019| | 0020| | 0021| | 0022| Adopted_______________________ Not Adopted_______________________ | 0023| (Chief Clerk) (Chief Clerk) | 0024| | 0025| | 0001| Date ________________________ | 0002| | 0003| | 0004| The roll call vote was 7 For 0 Against | 0005| Yes: 7 | 0006| No: 0 | 0007| Excused: Griego, Leavell, McKibben | 0008| Absent: None | 0009| | 0010| | 0011| H0084CT1 | 0012| |